Protecting public health through diagnostics for all.
Primary.Health’s superpower is bringing healthcare to all people whenever and wherever they are, whether it’s a child in school, an uninsured mother with no primary care doctor, an international traveler at the airport, or an employee. We are providing public and enterprise-level health programs at scale. Primary.Health should win because we have helped millions of people access diagnostic and or vaccines services during the pandemic, many of whom are in underserved communities. In addition to keeping communities as safe as possible from COVID, our solution touches millions of day to day lives, and has enabled communities to keep schools open, while theaters were able to keep performing and manufacturing facilities were able to keep running. The data collected in our platform has been used by public health leaders to understand where the pandemic is hitting hardest and reallocate resources to areas where they would have greater impact. Our Covid testing infrastructure also enabled Primary to implement rapid diabetes screening programs in underserved Latinx communities in SF, engaging socioeconomically disadvantaged populations into care. Of the 923 individuals tested for Covid and pre rapid hemoglobin A1c testing, over a third of testers met criteria for prediabetes and 12% for diabetes. 80% of these participants reported a household income of less than $50,000. Primary’s community-based Covid and diabetes testing program is a novel service that will serve as a model for building engagement and care services that expand access to treatment for chronic diseases that disproportionately affect lower income populations.
Primary.Health is building health equity at-scale by closing the healthcare accessibility gap. Healthcare services delivered in a traditional setting can hold many barriers for individuals seeking care. From language, location to technology, healthcare services often overlook the needs of many and focus on the needs of the few. That’s what Primary.Health is addressing. With more than 9,700 locations, 2,400 partner organizations, 1.4 million vaccine doses and over 11.5 million tests administered, Primary.Health is simplifying public health. Notably, 58.3% of clients reported that they were able to get vaccinated earlier because of the neighborhood vaccination site. Our features are customized to the community with usability and features designed to serve 99% of a community (mobile optimized, telephonic workflows, strong back-up/redundancy workflows for low internet or power). That forward thinking allows us to meet current and future roadblocks to healthcare access. A real-world example of this is through Primary.Health’s partnership with California schools. During the peak of the pandemic, schools were scrambling to organize their efforts. Primary.Health stepped in and is currently serving ~40% of schools in the state of CA and has created COVD-19 programs to ensure the safety of teachers and faculty, students and parents— through the program’s focus on testing protocol, vaccination records and outbreak communication. Our easy-to-use software has ensured that over 6 million individuals are receiving test kits, reporting results that enable faculty to flag positivity rates and deliver treatment to severe cases.
Our partner “Unidos en Salud” (United in Health) has utilized Primary.Health’s platform to uncover various strategies on the COVID-19 programs they deployed. In the Journal of PLOS ONE, titled: A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice, tested the theory that a community-centered vaccination strategy that included mobilization, vaccination and “activation” components could successfully reach an underserved Latinx population. In a 16-week period more than 20,000 registered to receive vaccine doses. Nearly 3,000 clients who took a survey about their experiences reported three reasons why they chose the site - 1.) it was in their neighborhood (29%), 2.) scheduling was easy and convenient (26.7%) and 3.) because someone they trusted had recommended it (18%) and lastly, Latinx clients were more likely to choose the site due to its bilingual staff. In medRxiv, a study titled: Direct Comparison of SARS Co-V-2 Nasal RT- PCR and Rapid Antigen Test (BinaxNOWTM) at a Community Testing Site During an Omicron Surge, tested the theory of PRC vs. Antigen test effectiveness. In 731 people seeking testing at a walk-up San Francisco community site over a two-day period uncovered that PCR testings are just as effective in detecting variants, like Omicron. The BinaxNOW tests detected 43 of 59 RT-PCR positive persons who were asymptomatic for a sensitivity of 89.8% (0.81-0.97); sensitivity was 97.6% (95% CI 95-100%) for persons with symptoms.
